BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 20825302)

  • 21. Can sorafenib cause hypothyroidism?
    Robinson SI; Hobday TJ; Sathananthan A; Morris JC; McWilliams RR
    J Chemother; 2007 Jun; 19(3):352-3. PubMed ID: 17594936
    [No Abstract]   [Full Text] [Related]  

  • 22. Keratoacanthomas associated with sorafenib therapy.
    Kong HH; Cowen EW; Azad NS; Dahut W; Gutierrez M; Turner ML
    J Am Acad Dermatol; 2007 Jan; 56(1):171-2. PubMed ID: 17190642
    [No Abstract]   [Full Text] [Related]  

  • 23. Managing patients receiving sorafenib for advanced hepatocellular carcinoma: a case study.
    Hull D; Armstrong C
    Int J Palliat Nurs; 2010 May; 16(5):249-54. PubMed ID: 20679973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. All that glitters: sorafenib.
    Abbass K; Dewani S; Markert R; Kaplon MK; Baumann MA
    Intern Med; 2011; 50(7):797. PubMed ID: 21467725
    [No Abstract]   [Full Text] [Related]  

  • 25. Sorafenib in advanced hepatocellular carcinoma.
    Palmer DH
    N Engl J Med; 2008 Dec; 359(23):2498; author reply 2498-9. PubMed ID: 19065750
    [No Abstract]   [Full Text] [Related]  

  • 26. Sorafenib for recurrent hepatocellular carcinoma after liver transplantation.
    Yoon DH; Ryoo BY; Ryu MH; Lee SG; Hwang S; Suh DJ; Lee HC; Kim TW; Ahn CS; Kim KH; Moon DB; Kang YK
    Jpn J Clin Oncol; 2010 Aug; 40(8):768-73. PubMed ID: 20494947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of variant angina in a patient under chronic treatment with sorafenib.
    Porto I; Leo A; Miele L; Pompili M; Landolfi R; Crea F
    Nat Rev Clin Oncol; 2010 Aug; 7(8):476-80. PubMed ID: 20479781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sorafenib.
    Hasskarl J
    Recent Results Cancer Res; 2010; 184():61-70. PubMed ID: 20072831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical observation of sorafenib monotherapy in Chinese patients with advanced hepatocellular carcinoma].
    Xu L; Li P; Lin XJ; Yuan YF; Zhang YQ; Chen MS
    Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):58-61. PubMed ID: 19538872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sorafenib therapy in patients with hepatocellular carcinoma before liver transplantation.
    Rowe IA
    Hepatology; 2010 Sep; 52(3):1171-2. PubMed ID: 20812364
    [No Abstract]   [Full Text] [Related]  

  • 31. Myositis due to Sorafenib intake in a patient with hepatocellular carcinoma.
    Diaz-Sanchez A; Rodriguez-Salas N; Aramendi T; Balbin E
    Dig Liver Dis; 2011 Apr; 43(4):333-4. PubMed ID: 21215716
    [No Abstract]   [Full Text] [Related]  

  • 32. Sorafenib-induced bilateral osteonecrosis of femoral heads.
    Guillet M; Walter T; Scoazec JY; Vial T; Lombard-Bohas C; Dumortier J
    J Clin Oncol; 2010 Jan; 28(2):e14. PubMed ID: 19884542
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical management and case reports for the treatment of hepatocellular carcinoma with sorafenib.
    Frenette CT; Frederick RT; Gish RG
    J Clin Gastroenterol; 2011 Sep; 45(8):733-7. PubMed ID: 20930642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hepatocellular carcinoma management in the era of sorafenib].
    Rosmorduc O
    Gastroenterol Clin Biol; 2009 Apr; 33(4):327-33. PubMed ID: 19321281
    [No Abstract]   [Full Text] [Related]  

  • 35. Sorafenib in advanced hepatocellular carcinoma.
    Copur MS
    N Engl J Med; 2008 Dec; 359(23):2498; author reply 2498-9. PubMed ID: 19065701
    [No Abstract]   [Full Text] [Related]  

  • 36. Probable sorafenib-induced reversible encephalopathy in a patient with hepatocellular carcinoma.
    Dogan E; Aksoy S; Arslan C; Dede DS; Altundag K
    Med Oncol; 2010 Dec; 27(4):1436-7. PubMed ID: 20012235
    [No Abstract]   [Full Text] [Related]  

  • 37. Sorafenib: in hepatocellular carcinoma.
    Simpson D; Keating GM
    Drugs; 2008; 68(2):251-8. PubMed ID: 18197728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sorafenib in advanced hepatocellular carcinoma].
    Sauerbruch T; Gonzalez-Carmona AM; Nitschmann S
    Internist (Berl); 2009 Nov; 50(11):1290-2. PubMed ID: 19771405
    [No Abstract]   [Full Text] [Related]  

  • 39. Sorafenib in liver cancer--just the beginning.
    Roberts LR
    N Engl J Med; 2008 Jul; 359(4):420-2. PubMed ID: 18650519
    [No Abstract]   [Full Text] [Related]  

  • 40. Developing better treatments in hepatocellular carcinoma.
    Duffy A; Greten T
    Expert Rev Gastroenterol Hepatol; 2010 Oct; 4(5):551-60. PubMed ID: 20932140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.